Users Coming Off Slimming Injections Gain Back Weight Four Times Faster Than Dieters

Fresh analysis suggests that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end conventional diet and exercise programs.

Published data in a leading health publication demonstrates that while obese people can lose substantial amounts of their body weight while on the medication, the weight is regained at an estimated rate of nearly a kilo each month after stopping.

"People purchasing these treatments need to be aware of the potential of fast weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a return to original mass in about 18 months.

Comparing Approaches

The research, which looked at dozens of trials involving thousands of participants, compared the effects of the injectable medications with conventional dieting.

Researchers emphasize that people who shed pounds through lifestyle changes alone usually experience a slower creep back—around 100 grams monthly—once they finish.

Explaining the Fast Regain

Nutrition scientists suggest the way of the drugs accounts for the heightened regain.

These medications copy a natural hormone called GLP-1, which helps regulate appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this hormone supplement results in hunger is no longer kept in check, making binge eating far more likely."

An Ongoing Condition?

Medical guidelines suggest the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.

Many experts contend that, considering the high risk of weight regain, the therapy should be considered long-term.

This opinion is echoed by pharmaceutical companies, who note that the results "emphasize the chronic character of obesity," akin to managing diseases like hypertension.

User Accounts

Individuals who have stopped the medication report a intense return of appetite.

"It felt as if something activating and you become extremely hungry," recalled an individual.

This difficulty is compounded if patients have not established sustainable dietary or behavioural changes during treatment.

Significant Interest

Figures show that millions of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.

• Adoption is greater among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion access the drugs through private healthcare rather than public health services.

Finally, experts emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle management.